Immune-related adverse events of biological immunotherapies used in COVID-19

The use of biological immunotherapeutic drugs is one of the options currently being evaluated and employed to manage COVID-19, specifically monoclonal antibodies, which have shown benefit by regulating the excessive immune response seen in patients with severe infection, known as a cytokine storm. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Baracaldo-Santamaría, Daniela, Barros-Arias, Giovanna María, Hernández-Guerrero, Felipe, De-La-Torre, Alejandra, Calderon-Ospina, Carlos-Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461090/
https://www.ncbi.nlm.nih.gov/pubmed/36091800
http://dx.doi.org/10.3389/fphar.2022.973246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461090/
https://www.ncbi.nlm.nih.gov/pubmed/36091800
http://dx.doi.org/10.3389/fphar.2022.973246

Ejemplares similares